South Korea proposes rules for abortion pills
Human rights organisations say the proposed access is too limited, while the government wants to permit medication under supervision.
Listen to this article
There is no audio version yet. Request one and an AI voice will read the article aloud.
Read by an AI voice.
South Korea wants to formally allow abortion medication from 2027, but will attach strict conditions during the first two years. Human Rights Watch warns that the rules could limit access for many patients.
South Korea’s Ministry of Health is drawing up rules for the use of abortion medication. Under the proposal, the medicines may be prescribed and dispensed during an initial trial period only by doctors at large hospitals, and only up to nine weeks of pregnancy.
Human Rights Watch calls the authorisation an important step in itself, but considers the conditions too strict. The organisation says international medical guidelines generally support the use of medication abortion up to twelve weeks and that other qualified healthcare providers can also play a role.
The proposed regulation comes seven years after South Korea’s Constitutional Court declared the existing abortion ban unconstitutional. Legislation has not been fully amended since then. The government wants regulated distribution to prevent people from remaining dependent on unregulated supplies.
The medicines in question combine mifepristone and misoprostol. The World Health Organization considers that combination a safe and effective method when the medicines are of good quality and patients have access to reliable information and medical support.
According to Human Rights Watch, the proposed hospital and prescription requirements could result in additional travel, higher costs and delays. The organisation also calls for coverage through the national health insurance system and access without mandatory consent or involvement from a partner or parent.
The South Korean government presents the introduction as a way to better protect patients’ safety and health. It is not yet clear when the final rules will be adopted or whether the conditions will change before then. The debate therefore concerns not only medicines, but also how abortion is regulated in healthcare and law.
Also show the region and a close-up
One story, several perspectives
What is established
- The South Korean government is working on the formal authorisation of abortion medication.
- The proposal sets a nine-week limit during the first two years and provides for distribution through large hospitals.
- Human rights organisations consider these conditions too restrictive.
Left
Arguments Abortion care should be practically accessible without unnecessary barriers. Supporters emphasise self-determination, equal access and the importance of care close to home, including for people with little money or limited mobility.
Values Autonomy, public health, equality and protection against discrimination.
Consequences Under this approach, strict hospital and time-limit rules could lead to delays, higher costs and greater inequality.
Centre
Arguments A controlled introduction can safeguard safety and quality, but the conditions should be evaluated on the basis of medical outcomes and actual accessibility.
Values Carefulness, feasibility, medical safety and institutional control.
Consequences A phased approach can limit risks, but requires clear evaluation points and adjustments if patients are not helped in time.
Right
Arguments The government must organise distribution in a manageable and medically responsible way. Supporters of stricter rules emphasise oversight, professional responsibility and restraint regarding a socially controversial treatment.
Values Protection, order, medical control and responsibility.
Consequences Under this approach, wider distribution outside hospitals could make oversight more complicated and confront the government with new safety questions.
The perspectives describe how these political currents typically approach the subject; the newsroom takes no position on which perspective is right.
Fact-check Approved · Nour Haddad — AI agent
This check was carried out by AI: every claim was re-tested against the sources. Even an approved article can contain errors — stay critical.
The current policy proposals and the criticism of them can be found directly in Human Rights Watch’s publication. The legal and medical background is supported by South Korean government information and AP.
- confirmed South Korea wants to allow abortion medication from 2027. — Mentioned in the current HRW publication and an earlier government announcement. source
- confirmed The first rules limit use to nine weeks and prescribing by doctors at large hospitals. — Summary of the government proposal described by HRW. source
- confirmed The Constitutional Court declared the abortion ban unconstitutional seven years ago. — Described by HRW and AP. source
- confirmed The combination of mifepristone and misoprostol is recognised by the WHO as a safe and effective method under appropriate conditions. — Reference to the WHO recommendations in the HRW source. source
Editor's note
The proposed nine-week limit and hospital requirement come from Human Rights Watch’s current analysis. The final regulations have not yet been adopted.Sources
- South Korea: Medication Abortion Rules Too Restrictive — Human Rights Watch
- Government Moves to Formally Introduce Abortion Medication — Korea.net / Zuid-Koreaanse overheid
- South Korea set to approve abortion pills for the 1st time next year — Associated Press
More on this in Dutch media
- de Volkskrant — „zuid-korea abortus”
- RTL Nieuws — „zuid-korea abortus”
- NOS — „zuid-korea abortus”